ITCI
Intra-Cellular Therapies Inc.
ITCI
ITCI
Delisted
ITCI was delisted on the 1st of April, 2025.
129 hedge funds and large institutions have $454M invested in Intra-Cellular Therapies Inc. in 2016 Q4 according to their latest regulatory filings, with 29 funds opening new positions, 50 increasing their positions, 26 reducing their positions, and 29 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
0% more first-time investments, than exits
New positions opened: 29 | Existing positions closed: 29
2% less funds holding
Funds holding: 131 → 129 (-2)
Holders
129
Holding in Top 10
1
Calls
$6.09M
Puts
$1.88M
Top Buyers
| 1 | +$18.2M | |
| 2 | +$14.2M | |
| 3 | +$6.84M | |
| 4 |
WA
Wasatch Advisors
Salt Lake City,
Utah
|
+$3.91M |
| 5 |
BB
BB Biotech
Schaffhausen,
Switzerland
|
+$3.4M |
Top Sellers
| 1 | -$9.14M | |
| 2 | -$5.13M | |
| 3 | -$4.75M | |
| 4 |
Jennison Associates
New York
|
-$4.36M |
| 5 |
TCM
TimesSquare Capital Management
New York
|
-$3.34M |